Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01251900 · ClinicalTrials.gov registry record

BRCA Mutations in Latinas

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
266
Enrollment target

NCT01251900: Completed study, sponsored by National Cancer Institute (NCI).

NCT01251900 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 266 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01251900 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
266 participants
Enrollment target

Study Summary

Background: \- BRCA1 and BRCA2 gene mutations have been linked to a higher risk of developing breast cancer and other cancers, and may be associated with types of breast cancer that are more difficult to treat and more likely to recur. New cancer treatments are being developed specifically to treat individuals who have these gene mutations. However, more information is needed about the prevalence of these mutations in minority populations, including Hispanic/Latino populations. To study these populations, researchers are interested in collecting genetic material (DNA) and medical history information from Hispanic/Latino women who have been diagnosed with breast cancer. Objectives: \- To collect saliva samples and medical and family history information from Hispanic/Latino women with breast cancer. Eligibility: \- Hispanic/Latino women at least 18 years of age who have been diagnosed with breast cancer. Design: * Participants will complete a questionnaire with information about place of birth, languages spoken by parents and grandparents, and information about their breast cancer diagnosis. * Participants will provide a saliva sample (2 to 3 tablespoons) for analysis. * No treatment will be provided as part of this protocol.

Trial Details

FieldValue
Enrollment Target 266 participants
Start Date 2011-07-07

Sponsor

National Cancer Institute (NCI)

3,257 total trials

What the Registry Record Tells You About NCT01251900

The ClinicalTrials.gov registry entry for NCT01251900 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 266 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01251900 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01251900 about?

NCT01251900 is a clinical study titled "BRCA Mutations in Latinas". Background: \- BRCA1 and BRCA2 gene mutations have been linked to a higher risk of developing breast cancer and other cancers, and may be associated with types of breast cancer that are more difficult to treat and more likely to recur. New cancer treatments are being developed specifically to treat...

What is the current status of trial NCT01251900?

This trial is currently completed. The enrollment target is 266 participants. The study started on 2011-07-07.

Who is sponsoring clinical trial NCT01251900?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.